Clinical Trial Update: S0002 - A Program to Quit Smoking With or Without Bupropion in Treating Patients With Stage I or II Non-Small Cell Lung Cancer Who Have Undergone Surgery [Phase 3]

View source ↗

Summary

SWOG's Phase 3 trial S0002 evaluating quitting smoking with or without bupropion in patients with Stage I or II non-small cell lung cancer after surgery was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 3 | Status: TERMINATED